Annamalai T, Saif L J, Lu Z, Jung K. 2015. Age-dependent variation in innate immune responses to porcine epidemic diarrhea virus infection in suckling versus weaned pigs. Veterinary Immunology & Immunopathology, 168, 193–202.

Bruun T, Andersson A C, Draper S J, Howarth M. 2018. Engineering a rugged nanoscaffold to enhance Plug-and-Display vaccination. ACS Nano, 12, 8855–8866.

Chang S H, Bae J L, Kang T J, Kim J, Chung G H, Lim C W, Laude H, Yang M S, Jang Y S. 2002. Identification of the epitope region capable of inducing neutralizing antibodies against the porcine epidemic diarrhea virus. Molecules and Cells, 14, 295–299.

Charlton H H, Lua L. 2017. Platform technologies for modern vaccine manufacturing. Vaccine, 35, 4480–4485.

Chattha K S, Roth J A, Saif L J. 2015. Strategies for design and application of enteric viral vaccines. Annual Review of Animal Biosciences, 3, 375.

Chen G, Bai Y, Li Z, Wang F, Fan X, Zhou X. 2020. Bacterial extracellular vesicle-coated multi-antigenic nanovaccines protect against drug-resistant Staphylococcus aureus infection by modulating antigen processing and presentation pathways. Theranostics, 10, 7131–7149.

Dhakal S, Renukaradhya G J. 2019. Nanoparticle-based vaccine development and evaluation against viral infections in pigs. Veterinary Research, 50, 90.

Dummer L A, Araujo I L, Finger P F, Dos S A J, Da R M, Conceicao F R, Fischer G, van Drunen L D H S, Leite F P. 2014. Immune responses of mice against recombinant bovine herpesvirus 5 glycoprotein D. Vaccine, 32, 2413–2419.

Edayati A K, Chua C L L, Smooker P, Lee K W. 2019. Nanoparticles in influenza subunit vaccine development: Immunogenicity enhancement. Influenza and Other Respiratory Viruses, 14, 92–101.

Graham B S, Gilman M, Mclellan J S. 2019. Structure-based vaccine antigen design. Annual Review of Medicine, 70, 91–104.

Guo T, Gao C, Hao J, Lu X, Xie K, Wang X, Li J, Zhou H, Cui W, Shan Z, Jiang Y, Qiao X, Tang L, Wang L, Li Y. 2022. Strategy of developing oral vaccine candidates against co-infection of porcine diarrhea viruses based on a lactobacillus delivery system. Frontiers in Microbiology, 13, 872550.

Havenar-Daughton C, Lee J H, Crotty S. 2017. Tfh cells and HIV bnAbs, an immunodominance model of the HIV neutralizing antibody generation problem. Immunological Reviews, 275, 49–61.

Holmgren J, Czerkinsky C. 2005. Mucosal immunity and vaccines. Nature Medicine, 11, S45–S53.

Hsia Y, Bale J B, Gonen S, Shi D, Sheffler W, Fong K K, Nattermann U, Xu C, Huang P S, Ravichandran R, Yi S, Davis T N, Gonen T, King N P, Baker D. 2016. Corrigendum: Design of a hyperstable 60-subunit protein icosahedron. Nature, 540, 150.

Hu C J, Chang W S, Fang Z S, Chen Y T, Wang W L, Tsai H H, Chueh L L, Takano T, Hohdatsu T, Chen H W. 2017. Nanoparticulate vacuolar ATPase blocker exhibits potent host-targeted antiviral activity against feline coronavirus. Scientific Reports, 7, 13043.

Jung K, Saif L J. 2021. Replication of porcine deltacoronavirus is limited in the gastrointestinal tract of neonatal piglets co-infected simultaneously or 16 hours prior with virulent porcine epidemic diarrhea virus. Veterinary Microbiology, 261, 109206.

Kayraklioglu N, Horuluoglu B, Klinman D M. 2021. CpG oligonucleotides as vaccine adjuvants. Methods in Molecular Biology, 2197, 51–85.

Kheirollahpour M, Mehrabi M, Dounighi N M, Mohammadi M, Masoudi A. 2020. Nanoparticles and vaccine development. Pharmaceutical Nanotechnology, 8, 6–21.

Kwong P D. 2017. What are the most powerful immunogen design vaccine strategies? A structural biologist’s perspective. Cold Spring Harbor Perspectives in Biology, 9, a029470.

Lederer K, Castano D, Gomez A D, Oguin T R, Wang S, Manzoni T B, Muramatsu H, Hogan M J, Amanat F, Cherubin P, Lundgreen K A, Tam Y K, Fan S, Eisenlohr L C, Maillard I, Weissman D, Bates P, Krammer F, Sempowski G D, Pardi N, et al. 2020. SARS-CoV-2 mRNA vaccines foster potent antigen-specific germinal center responses associated with neutralizing antibody generation. Immunity, 53, 1281–1295.

Li L, Fu F, Guo S, Wang H, He X, Xue M, Yin L, Feng L, Liu P. 2019. Porcine intestinal enteroids: A new model for studying enteric coronavirus porcine epidemic diarrhea virus infection and the host innate response. Journal of Virology, 93, e01682–18.

Li Y, Wang G, Wang J, Man K, Yang Q. 2017. Cell attenuated porcine epidemic diarrhea virus strain Zhejiang08 provides effective immune protection attributed to dendritic cell stimulation. Vaccine, 35, 7033–7041.

Li Y, Wu Q, Huang L, Yuan C, Wang J, Yang Q. 2018. An alternative pathway of enteric PEDV dissemination from nasal cavity to intestinal mucosa in swine. Nature Communications, 9, 3811.

Li Z, Ma Z, Li Y, Gao S, Xiao S. 2020. Porcine epidemic diarrhea virus: Molecular mechanisms of attenuation and vaccines. Microbial Pathogenesis, 149, 104553.

Lin Y, Sun B, Jin Z, Zhao K. 2022. Enhanced immune responses to mucosa by functionalized chitosan-based composite nanoparticles as a vaccine adjuvant for intranasal delivery. ACS Applied Materials & Interfaces, 14, 52691–52701.

Ma X, Zou F, Yu F, Li R, Yuan Y, Zhang Y, Zhang X, Deng J, Chen T, Song Z, Qiao Y, Zhan Y, Liu J, Zhang J, Zhang X, Peng Z, Li Y, Lin Y, Liang L, Wang G, et al. 2020. Nanoparticle vaccines based on the receptor binding domain (RBD) and heptad repeat (HR) of SARS-CoV-2 elicit robust protective immune responses. Immunity, 53, 1315–1330.

Mohankrishnan A, Patel H, Bhurani V, Parmar R, Yadav N, Dave N, Rana S, Gupta S, Madariya J, Vyas P. 2019. Inclusion of non-target antigen in vaccination favors generation of OVA specific CD4 memory T cells. Cellular Immunology, 337, 1–14.

Mota R M, Moreira J L, Souza M R, Horta M F, Teixeira S M, Neumann E, Nicoli J R, Nunes A C. 2006. Genetic transformation of novel isolates of chicken Lactobacillus bearing probiotic features for expression of heterologous proteins: A tool to develop live oral vaccines. BMC Biotechnology, 6, 2.

Negandaripour M N N S. 2017. Harnessing self-assembled peptide nanoparticles in epitope vaccine design. Biological Control (Theory and Application in Pest Management), 111, 575–596.

Oh J, Lee K W, Choi H W, Lee C. 2014. Immunogenicity and protective efficacy of recombinant S1 domain of the porcine epidemic diarrhea virus spike protein. Archives of Virology, 159, 2977–2987.

Okda F A, Lawson S, Singrey A, Nelson J, Hain K S, Joshi L R, Christopher-Hennings J, Nelson E A, Diel D G. 2017. The S2 glycoprotein subunit of porcine epidemic diarrhea virus contains immunodominant neutralizing epitopes. Virology, 509, 185–194.

Poles J, Alvarez Y, Hioe C E. 2014. Induction of intestinal immunity by mucosal vaccines as a means of controlling HIV infection. AIDS Research and Human Retroviruses, 30, 1027–1040.

Rahikainen R, Rijal P, Tan T K, Wu H J, Andersson A C, Barrett J R, Bowden T A, Draper S J, Townsend A R, Howarth M. 2021. Overcoming symmetry mismatch in vaccine nanoassembly through spontaneous amidation. Angewandte Chemie International Edition, 60, 321–330.

Song D, Huang D, Peng Q, Huang T, Chen Y, Zhang T, Nie X, He H, Wang P, Liu Q, Tang Y. 2015. Molecular characterization and phylogenetic analysis of porcine epidemic diarrhea viruses associated with outbreaks of severe diarrhea in piglets in Jiangxi, China 2013. PLoS ONE, 10, e120310.

Staats H F, Montgomery S P, Palker T J. 1997. Intranasal immunization is superior to vaginal, gastric, or rectal immunization for the induction of systemic and mucosal anti-HIV antibody responses. Aids Research and Human Retroviruses, 13, 945–952.

Steinman R M. 2001. Dendritic cells and the control of immunity: Enhancing the efficiency of antigen presentation. Mount Sinai Journal of Medicine, 68, 160–166.

Steinrigl A, Fernandez S R, Stoiber F, Pikalo J, Sattler T, Schmoll F. 2015. First detection, clinical presentation and phylogenetic characterization of porcine epidemic diarrhea virus in Austria. BMC Veterinary Research, 11, 310.

Tao W, Hurst B L, Shakya A K, Uddin M J, Ingrole R S, Hernandez-Sanabria M, Arya R P, Bimler L, Paust S, Tarbet E B, Gill H S, et al. 2017. Consensus M2e peptide conjugated to gold nanoparticles confers protection against H1N1, H3N2 and H5N1 influenza A viruses. Antiviral Research, 141, 62–72.

Tizard I R. 2020. Vaccination against coronaviruses in domestic animals. Vaccine, 38, 5123–5130.

Turlewicz-Podbielska H, Pomorska-Mol M. 2021. Porcine coronaviruses: Overview of the state of the art. Virologica Sinica, 36, 833–851.

Wang J, Huang L, Mou C, Zhang E, Wang Y, Cao Y, Yang Q. 2019a. Mucosal immune responses induced by oral administration recombinant Bacillus subtilis expressing the COE antigen of PEDV in newborn piglets. Bioscience Reports, 39, BSR20182028.

Wang Q, Vlasova A N, Kenney S P, Saif L J. 2019b. Emerging and re-emerging coronaviruses in pigs. Current Opinion in Virology, 34, 39–49.

Wang Y P, Liu D, Guo L J, Tang Q H, Wei Y W, Wu H L, Liu J B, Li S B, Huang L P, Liu C M. 2013. Enhanced protective immune response to PCV2 subunit vaccine by co-administration of recombinant porcine IFN-gamma in mice. Vaccine, 31, 833–838.

Won H, Lim J, Noh Y H, Yoon I, Yoo H S. 2020. Efficacy of porcine epidemic diarrhea vaccines: A systematic review and Meta-Analysis. Vaccines (Basel), 8, 642.

Yan Q, Liu X, Sun Y, Zeng W, Li Y, Zhao F, Wu K, Fan S, Zhao M, Chen J, Yi L. 2022. Swine enteric coronavirus: Diverse Pathogen-Host interactions. International Journal of Molecular Sciences, 23, 3953.

Zakeri B, Fierer J O, Celik E, Chittock E C, Schwarz-Linek U, Moy V T, Howarth M. 2012. Peptide tag forming a rapid covalent bond to a protein, through engineering a bacterial adhesin. Proceedings of the National Academy of Sciences of the United States of America, 109, E690–E697.

Zhang B, Chao C W, Tsybovsky Y, Abiona O M, Hutchinson G B, Moliva J I, Olia A S, Pegu A, Phung E, Stewart-Jones G, Verardi R, Wang L, Wang S, Werner A, Yang E S, Yap C, Zhou T, Mascola J R, Sullivan N J, Graham B S, et al. 2020. A platform incorporating trimeric antigens into self-assembling nanoparticles reveals SARS-CoV-2-spike nanoparticles to elicit substantially higher neutralizing responses than spike alone. Scientific Reports, 10, 18149.

Zhang E, Wang J, Li Y, Huang L, Wang Y, Yang Q. 2020. Comparison of oral and nasal immunization with inactivated porcine epidemic diarrhea virus on intestinal immunity in piglets. Experimental and Therapeutic Medicine, 20, 1596–1606.

Zhang H, Zou C, Peng O, Ashraf U, Xu Q, Gong L, Fan B, Zhang Y, Xu Z, Xue C, Wei X, Zhou Q, Tian X, Shen H, Li B, Zhang X, Cao Y. 2023. Global dynamics of porcine enteric coronavirus PEDV epidemiology, evolution, and transmission. Molecular Biology and Evolution, 40, msad052.

Zhou P, Fan H, Lan T, Yang X L, Shi W F, Zhang W, Zhu Y, Zhang Y W, Xie Q M, Mani S, Zheng X S, Li B, Li J M, Guo H, Pei G Q, An X P, Chen J W, Zhou L, Mai K J, Wu Z X, et al. 2018. Fatal swine acute diarrhoea syndrome caused by an HKU2-related coronavirus of bat origin. Nature, 556, 255–258.